Israel Active

The xBar sensor from Israel’s Exero Medical (see previously) is about to begin a Phase 3 pivotal clinical trial in the USA and Israel. The device aims to immediately detect post-operative leakage following gastro surgery, which is fatal in 40% of affected cases.

Researchers at Tel Aviv University have discovered in the laboratory that two existing medicines can be used to enhance treatments against bone cancer. It is important as bone cancer is often the result of metastasis (spreading) in breast cancer patients.

Some 500,000 spinal cord injuries are sustained annually. Israel’s NurExone takes exosomes (nanoscopic particles released by cells to pass messages to one another) from bone marrow, adds siRNA to help regenerate cells, and delivers them via the nose and blood brain barrier to heal the spine.

Scientists at Israel’s Technion have developed a robotic hand that allows the wearer to play the piano and type on a keyboard. The device is intended to be used as a prosthetic for those who have lost limbs, e.g., in the War, and can give the wearer skills that they never had before.

Israeli-founded Impact.51 is the first startup studio in the world to focus solely on women’s health. 51% of the world receives insufficient funding, research, & support. Impact.51 aims to create inventive solutions addressing critical gaps in women’s health. After Oct 7, the priority is trauma.

Israel’s PsyRx has developed a radically new treatment for depression. It combines an approved medicine from the SSRI family with a low dosage of ibogaine. PsyRx has just completed a successful lab toxicological safety study for the treatment to help it progress to human trials.

Israel’s Madrigal Mental Care is based in Kibbutz Reim – one of the communities devasted by Hamas on Oct 7.  So, it is remarkable that it has just announced the successful completion of its pivotal nanotechnology research on using Ketamine as a treatment for PTSD & depression.

A new Trauma Institute has been established at the Hebrew University of Jerusalem. It will design new clinical approaches to and train therapists to deal with the nationwide traumas following the Oct 7 Hamas attacks. The new Institute has raised 25% of its budget and is seeking support.   (US donors)

Zuckerman Faculty Scholar Dr. Arielle Fischer runs the Fischer Biomechanics and Wearable Technology Lab at Israel’s Technion Institute. Her lab develops biomechanical tools and wearable devices to detect, prevent, and correct musculoskeletal movement disorders.

Rafa Laboratories is one of Israel’s oldest pharmaceutical companies. For example, it has been supplying autoinjectors for over 30 years, for global medical conditions including seizures and now (partnering USA’s BARDA) to counter nerve agent and pesticide poisoning.